DePrince Race & Zollo Inc (DRZ)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-662,902
Closed -$22M 265
2017
Q2
$22M Buy
662,902
+4,307
+0.7% +$143K 0.45% 108
2017
Q1
$21.1M Sell
658,595
-136,779
-17% -$4.39M 0.44% 115
2016
Q4
$28.8M Buy
795,374
+202,650
+34% +$7.35M 0.56% 89
2016
Q3
$27.3M Buy
592,724
+26,640
+5% +$1.23M 0.58% 88
2016
Q2
$28.4M Buy
566,084
+486,894
+615% +$24.5M 0.58% 93
2016
Q1
$4.24M Buy
+79,190
New +$4.24M 0.09% 159
2015
Q1
Sell
-18,630
Closed -$1.07M 299
2014
Q4
$1.07M Sell
18,630
-5,700
-23% -$328K 0.01% 257
2014
Q3
$1.31M Sell
24,330
-837,201
-97% -$45M 0.02% 257
2014
Q2
$45.2M Sell
861,531
-47,200
-5% -$2.47M 0.53% 80
2014
Q1
$48M Sell
908,731
-189,920
-17% -$10M 0.58% 69
2013
Q4
$44M Sell
1,098,651
-125,300
-10% -$5.02M 0.56% 70
2013
Q3
$46.2M Buy
1,223,951
+47,633
+4% +$1.8M 0.63% 57
2013
Q2
$46.1M Buy
+1,176,318
New +$46.1M 0.63% 56